Ion AmpliSeq™ Community Panels
OncoNetwork Consortium:Get the researchers’ perspective
on community panels
Leveraging the power of the Ion Community and Ion AmpliSeq™ technology, Life Technologies delivers Ion AmpliSeq™ Community Panels. Designed with leading disease researchers, Ion AmpliSeq™ Community Panels provide the ability to selectively analyze gene content with the aim of transforming cancer and inherited disease research. Your disease research is greatly simplified with the community wide-availability of these panels. In addition, for maximum flexibility, you will be able to rapidly customize any Ion AmpliSeq™ Community Panel to advance clinical research to fit your own project requirements.
Developed with input from the community, available to the community
Ion AmpliSeq™ Community Panels, designed with input from leading researchers, are currently being verified for performance and will soon be available for any lab to order via ampliseq.com:
The content provided herein may relate to products that have not been officially released and is subject to change without notice.
For Research Use Only. Not for use in diagnostic procedures.
Ion AmpliSeq™ CFTR PanelAnalyzes all exons, intron-exon boundaries and UTRs that contain common mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. Mutations of this gene are associated with cystic fibrosis.
Ion AmpliSeq™ Cardio PanelAnalyzes all exons and UTRs of 62 genes commonly implicated in cardiomyopathies, channelopathies/arrhythmias, and structural heart defects.
Ion AmpliSeq™ AML Panel
- Analyzes the coding regions of known mutations in 21 commonly mutated genes in acute myeloid leukemia (AML).
- Design is currently in progress with input from Drs. Kojo Elenitoba-Johnson and Bryan Betz from the Molecular Diagnostics Laboratory at the University of Michigan, Department of Pathology.